Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Diagnosis and Mechanism of Pleural Effusion

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03997669
Recruitment Status : Active, not recruiting
First Posted : June 25, 2019
Last Update Posted : August 29, 2019
Sponsor:
Information provided by (Responsible Party):
Yang Jin, Wuhan Union Hospital, China

Tracking Information
First Submitted Date January 22, 2019
First Posted Date June 25, 2019
Last Update Posted Date August 29, 2019
Actual Study Start Date July 1, 2019
Estimated Primary Completion Date February 1, 2020   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: August 26, 2019)
overall survival [ Time Frame: 1 years ]
the percentage of people in a group who are alive after a year for malignant pleural effusion
Original Primary Outcome Measures
 (submitted: June 22, 2019)
overall survival [ Time Frame: 1 years ]
Change History
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title The Diagnosis and Mechanism of Pleural Effusion
Official Title The Diagnosis and Mechanism of Pleural Effusion
Brief Summary The diagnosis, treatment and mechanism of pleural diseases
Detailed Description The diagnosis and treatment of benign and malignant pleural effusions, the mechanisms of pleural diseases
Study Type Observational
Study Design Observational Model: Case-Control
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Retention:   Samples With DNA
Description:
The blood and pleural effusions if there is any, will be collected and detected
Sampling Method Non-Probability Sample
Study Population patients with pleural effusion
Condition Pleural Diseases
Intervention Other: Collection of pleural effusion
Detection of pleural effusion
Study Groups/Cohorts
  • experimental group
    patients with malignant pleural effusion
    Intervention: Other: Collection of pleural effusion
  • control group
    patients with benign pleural effusion
    Intervention: Other: Collection of pleural effusion
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Active, not recruiting
Actual Enrollment
 (submitted: June 22, 2019)
1000
Original Estimated Enrollment Same as current
Estimated Study Completion Date August 1, 2020
Estimated Primary Completion Date February 1, 2020   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

Patients with pleural effusion, who has not been treated

Exclusion Criteria:

Patients with pleural effusion, who has already been treated

Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years to 80 Years   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries China
Removed Location Countries  
 
Administrative Information
NCT Number NCT03997669
Other Study ID Numbers 001
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No
IPD Sharing Statement
Plan to Share IPD: Undecided
Responsible Party Yang Jin, Wuhan Union Hospital, China
Study Sponsor Wuhan Union Hospital, China
Collaborators Not Provided
Investigators
Study Director: Jinshuo Fan, MD Key Laboratory of Respiratory Diseases of the Ministry of Health
PRS Account Wuhan Union Hospital, China
Verification Date June 2019